Showing items 1 - 4 of 4

Your selections:

Prognostic stratification of HPV-associated oropharyngeal cancer based on CD103+ immune cell abundance in patients treated on TROG 12.01 and De-ESCALaTE randomized trials

- Rischin, D., Mehanna, H., Porceddu, S., Wratten, C., Robinson, M., Solomon, B. J., Young, R. J., Bressel, M., Dunn, J., Corry, J., Soni, P., Fulton-Lieuw, T., Iqbal, G., Kenny, L.

The impact of human papillomavirus (HPV) associated oropharyngeal squamous cell carcinoma (OPSCC) on nutritional outcomes

- Harrowfield, Jane, Isenring, Elizabeth, Kiss, Nicole, Laing, Erin, Lipson-Smith, Ruby, Britton, Ben

Validation of local p16 testing for determination of human papilloma virus status eligibility on a low risk oropharyngeal cancer trial - A Trans-Tasman Radiation Oncology Group study

- Young, Richard J., Solomon, Benjamin, Rischin, Danny, Corry, June, Angel, Christopher, Kenny, Lizbeth, Porceddu, Sandro, Wratten, Christopher, Macann, Andrew, Jackson, James E., Herschtal, Alan

Effect of p16 status on the quality-of-life experience during chemoradiation for locally advanced oropharyngeal cancer: a substudy of randomized trial Trans-Tasman Radiation Oncology Group (TROG) 02.02 (HeadSTART)

- Ringash, Jolie, Fisher, Richard, Peters, Lester, Trotti, Andy, O'Sullivan, Brian, Corry, June, Kenny, Lizbeth, Van Den Bogaert, Walter, Wratten, Chris, Rischin, Danny

  • 1
  • Disclaimer
  • Privacy
  • Copyright
  • Contact
  • Deposit